Related Experiment Video
Updated: Jul 31, 2026

17:28
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
[A toxicological study of the preparation Phytomix-40]
Gigiena I Sanitariia
|November 24, 1999
Summary
The new cancer treatment Phitomix-40 (PM-40), containing 40 plant extracts, shows low toxicity in animal studies. Its high LD50 values indicate a good safety profile for potential use in cancer therapy.
Area of Science:
- Phytochemistry
- Toxicology
- Pharmacology
Context:
- The development of novel cancer therapeutics is crucial.
- Plant-based preparations offer potential alternative treatments.
- Phitomix-40 (PM-40) is a new multi-extract herbal preparation for cancer treatment.
Purpose:
- To present the toxicological evaluation of Phitomix-40 (PM-40).
- To assess the safety profile of PM-40 in preclinical animal models.
- To determine the lethal dose 50 (LD50) of PM-40.
Summary:
- Phitomix-40 (PM-40) is composed of 40 diverse plant extracts.
- Animal experiments revealed low toxicity for PM-40.
- LD50 values exceeded 20 ml/kg in rats and 15 ml/kg in mice, indicating a wide safety margin.
Impact:
- The findings support the potential use of Phitomix-40 (PM-40) as a safe adjunct in cancer treatment.
- Low toxicity suggests a favorable risk-benefit ratio for further clinical investigation.
- This toxicological data is essential for advancing PM-40 towards human trials.

